Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Hypoalbuminemia on Cefoperazone/Sulbactam Induced Coagulopathy in Post-Operative Surgical Patients

NCT07773584 is registered in ClinicalTrials.gov with Sheikh Zayed Federal Postgraduate Medical Institute as lead sponsor.

NCT NCT07773584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07773584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Hypoalbuminemia on Cefoperazone/Sulbactam Induced Coagulopathy in Post-Operative Surgical Patients
Lead sponsor
Sheikh Zayed Federal Postgraduate Medical Institute
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2027
Completion date
October 31, 2027
Enrollment
108 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cefoperazone/sulbactam induced coagulopayjy